Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults – Capturing the State of the Art-Reference-Cited by-同舟云学术

Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults – Capturing the State of the Art

Published:2024-06-10 Issue:9 Volume:69 Page:692-694
ISSN:0706-7437
Container-title:The Canadian Journal of Psychiatry
language:en
Short-container-title:Can J Psychiatry

Author:

Beck Katherine¹²^ORCID,Young Allan H²³

Affiliation:

1. Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

2. South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Kent, UK

3. Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK

Funder

National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London

National Institute for Health and Care Research

Rosetrees Trust and Stoneygate Trust

Publisher

SAGE Publications

Link

https://journals.sagepub.com/doi/pdf/10.1177/07067437241259896

Reference9 articles.

1. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies

2. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary

3. Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines

4. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis

5. Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment